TrialNature medicine2026

Trabectedin and low-dose irinotecan to target EWS::FLI1 in Ewing sarcoma: a phase 1/2 trial.

Patrick J Grohar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.